Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial
Background Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates. Purpose To assess the clinical and microbiological out...
Gespeichert in:
Veröffentlicht in: | Clinical implant dentistry and related research 2021-08, Vol.23 (4), p.543-554 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 554 |
---|---|
container_issue | 4 |
container_start_page | 543 |
container_title | Clinical implant dentistry and related research |
container_volume | 23 |
creator | Park, Seung‐Hyun Song, Young Woo Cha, Jae‐Kook Lee, Jung‐Seok Kim, Young‐Taek Shin, Hyun‐Seung Lee, Dong‐Won Lee, Jae Hyun Kim, Chang‐Sung |
description | Background
Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates.
Purpose
To assess the clinical and microbiological outcomes of administering metronidazole in combination with minocycline as a local adjunct to the nonsurgical treatment of peri‐implantitis.
Materials and methods
One hundred and eighteen subjects with peri‐implantitis were recruited in a four‐center, three‐arm, and 12‐week randomized controlled trial. Subjects were randomly assigned to receive one of the following treatments: (a) MM—mechanical debridement + metronidazole‐minocycline ointment, (b) MC—mechanical debridement + minocycline ointment, (c) NST—mechanical debridement only.
Results
Except for four subjects who was excluded during the trial, a total of 114 patients with 114 implants (one implant per each patient) finally completed the trial and were included in the analyses. Multivariate logistic regression analysis revealed that the treatment success rates (absence of bleeding or suppuration on probing, and sites showing pocket probing depth [PPD] ≥5 mm) on at 12 weeks were higher in MM‐group patients (31.6%) and MC‐group patients (20.5%) compared to NST‐group patients (2.7%; p = 0.011 and 0.040, respectively). Subjects with deepest PPD ≥8 mm showed a significant difference in the PPD reduction between MM and MC groups at week 4 (p = 0.025) and week 12 (p = 0.047). Detection ratio of Tannerella forsythia was significantly lower for MM group than MC group (p = 0.038).
Conclusions
Additive use of either MM or MC results in significantly higher treatment success rates compared to sole mechanical debridement in nonsurgical treatment of peri‐implantitis. Moreover, MM contributes to a significantly greater reduction in the PPD compared to MC in deep pockets (cris.nih.go.kr KCT0004557). |
doi_str_mv | 10.1111/cid.13006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2543446862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2543446862</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3306-fc181f03254742654136ba2ec0b2640f5f6e9ee935b65db618358032258b764b3</originalsourceid><addsrcrecordid>eNp1kc9O3DAQxqOqSKWUA29gqZf2EPCf2Ov0tlpaQELqBc6R40zorBx7aztFy6mP0ANP2CfBkJ6QOpcZ6fvNNyN9VXXC6CkrdWZxOGWCUvWmOmQrqmvNqX5bZslFTXXbvqvep7SllDOm2GH1uB62s7cZfwGZE5AwkglyDB4H8xAc_P39Z0If7N469EVGnyfwmaAn-QcQH3ya4x1a40iOYBaxmOwgYtnFaeeMz5gxfSFrMs0uoy0IRBKNH8KEDzAQG3w56VwZc0TjPlQHo3EJjv_1o-r229ebzWV9_f3iarO-rq0QVNWjZZqNVHDZrBquZMOE6g0HS3uuGjrKUUEL0ArZKzn0imkhdcG51P1KNb04qj4tvrsYfs6QcjdhsuDKyxDm1BVj0TRKK17Qj6_QbZijL98VSgm1aqVWhfq8UDaGlCKM3S7iZOK-Y7R7zqcr-XQv-RT2bGHv0cH-_2C3uTpfNp4AMw-VwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2563679586</pqid></control><display><type>article</type><title>Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Park, Seung‐Hyun ; Song, Young Woo ; Cha, Jae‐Kook ; Lee, Jung‐Seok ; Kim, Young‐Taek ; Shin, Hyun‐Seung ; Lee, Dong‐Won ; Lee, Jae Hyun ; Kim, Chang‐Sung</creator><creatorcontrib>Park, Seung‐Hyun ; Song, Young Woo ; Cha, Jae‐Kook ; Lee, Jung‐Seok ; Kim, Young‐Taek ; Shin, Hyun‐Seung ; Lee, Dong‐Won ; Lee, Jae Hyun ; Kim, Chang‐Sung</creatorcontrib><description>Background
Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates.
Purpose
To assess the clinical and microbiological outcomes of administering metronidazole in combination with minocycline as a local adjunct to the nonsurgical treatment of peri‐implantitis.
Materials and methods
One hundred and eighteen subjects with peri‐implantitis were recruited in a four‐center, three‐arm, and 12‐week randomized controlled trial. Subjects were randomly assigned to receive one of the following treatments: (a) MM—mechanical debridement + metronidazole‐minocycline ointment, (b) MC—mechanical debridement + minocycline ointment, (c) NST—mechanical debridement only.
Results
Except for four subjects who was excluded during the trial, a total of 114 patients with 114 implants (one implant per each patient) finally completed the trial and were included in the analyses. Multivariate logistic regression analysis revealed that the treatment success rates (absence of bleeding or suppuration on probing, and sites showing pocket probing depth [PPD] ≥5 mm) on at 12 weeks were higher in MM‐group patients (31.6%) and MC‐group patients (20.5%) compared to NST‐group patients (2.7%; p = 0.011 and 0.040, respectively). Subjects with deepest PPD ≥8 mm showed a significant difference in the PPD reduction between MM and MC groups at week 4 (p = 0.025) and week 12 (p = 0.047). Detection ratio of Tannerella forsythia was significantly lower for MM group than MC group (p = 0.038).
Conclusions
Additive use of either MM or MC results in significantly higher treatment success rates compared to sole mechanical debridement in nonsurgical treatment of peri‐implantitis. Moreover, MM contributes to a significantly greater reduction in the PPD compared to MC in deep pockets (cris.nih.go.kr KCT0004557).</description><identifier>ISSN: 1523-0899</identifier><identifier>EISSN: 1708-8208</identifier><identifier>DOI: 10.1111/cid.13006</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Antibiotics ; Clinical trials ; Debridement ; Dentistry ; Metronidazole ; Minocycline ; multicenter randomized controlled trial ; nonsurgical therapy ; Ointments ; Patients ; peri‐implantitis ; Regression analysis ; Success ; Transplants & implants</subject><ispartof>Clinical implant dentistry and related research, 2021-08, Vol.23 (4), p.543-554</ispartof><rights>2021 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3306-fc181f03254742654136ba2ec0b2640f5f6e9ee935b65db618358032258b764b3</citedby><cites>FETCH-LOGICAL-c3306-fc181f03254742654136ba2ec0b2640f5f6e9ee935b65db618358032258b764b3</cites><orcidid>0000-0002-1410-9731 ; 0000-0003-1852-7989 ; 0000-0002-6906-7209 ; 0000-0002-5132-5783 ; 0000-0003-1835-5646 ; 0000-0003-1276-5978 ; 0000-0003-3902-1071 ; 0000-0003-2739-281X ; 0000-0002-6207-8036</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcid.13006$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcid.13006$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Park, Seung‐Hyun</creatorcontrib><creatorcontrib>Song, Young Woo</creatorcontrib><creatorcontrib>Cha, Jae‐Kook</creatorcontrib><creatorcontrib>Lee, Jung‐Seok</creatorcontrib><creatorcontrib>Kim, Young‐Taek</creatorcontrib><creatorcontrib>Shin, Hyun‐Seung</creatorcontrib><creatorcontrib>Lee, Dong‐Won</creatorcontrib><creatorcontrib>Lee, Jae Hyun</creatorcontrib><creatorcontrib>Kim, Chang‐Sung</creatorcontrib><title>Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial</title><title>Clinical implant dentistry and related research</title><description>Background
Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates.
Purpose
To assess the clinical and microbiological outcomes of administering metronidazole in combination with minocycline as a local adjunct to the nonsurgical treatment of peri‐implantitis.
Materials and methods
One hundred and eighteen subjects with peri‐implantitis were recruited in a four‐center, three‐arm, and 12‐week randomized controlled trial. Subjects were randomly assigned to receive one of the following treatments: (a) MM—mechanical debridement + metronidazole‐minocycline ointment, (b) MC—mechanical debridement + minocycline ointment, (c) NST—mechanical debridement only.
Results
Except for four subjects who was excluded during the trial, a total of 114 patients with 114 implants (one implant per each patient) finally completed the trial and were included in the analyses. Multivariate logistic regression analysis revealed that the treatment success rates (absence of bleeding or suppuration on probing, and sites showing pocket probing depth [PPD] ≥5 mm) on at 12 weeks were higher in MM‐group patients (31.6%) and MC‐group patients (20.5%) compared to NST‐group patients (2.7%; p = 0.011 and 0.040, respectively). Subjects with deepest PPD ≥8 mm showed a significant difference in the PPD reduction between MM and MC groups at week 4 (p = 0.025) and week 12 (p = 0.047). Detection ratio of Tannerella forsythia was significantly lower for MM group than MC group (p = 0.038).
Conclusions
Additive use of either MM or MC results in significantly higher treatment success rates compared to sole mechanical debridement in nonsurgical treatment of peri‐implantitis. Moreover, MM contributes to a significantly greater reduction in the PPD compared to MC in deep pockets (cris.nih.go.kr KCT0004557).</description><subject>Antibiotics</subject><subject>Clinical trials</subject><subject>Debridement</subject><subject>Dentistry</subject><subject>Metronidazole</subject><subject>Minocycline</subject><subject>multicenter randomized controlled trial</subject><subject>nonsurgical therapy</subject><subject>Ointments</subject><subject>Patients</subject><subject>peri‐implantitis</subject><subject>Regression analysis</subject><subject>Success</subject><subject>Transplants & implants</subject><issn>1523-0899</issn><issn>1708-8208</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kc9O3DAQxqOqSKWUA29gqZf2EPCf2Ov0tlpaQELqBc6R40zorBx7aztFy6mP0ANP2CfBkJ6QOpcZ6fvNNyN9VXXC6CkrdWZxOGWCUvWmOmQrqmvNqX5bZslFTXXbvqvep7SllDOm2GH1uB62s7cZfwGZE5AwkglyDB4H8xAc_P39Z0If7N469EVGnyfwmaAn-QcQH3ya4x1a40iOYBaxmOwgYtnFaeeMz5gxfSFrMs0uoy0IRBKNH8KEDzAQG3w56VwZc0TjPlQHo3EJjv_1o-r229ebzWV9_f3iarO-rq0QVNWjZZqNVHDZrBquZMOE6g0HS3uuGjrKUUEL0ArZKzn0imkhdcG51P1KNb04qj4tvrsYfs6QcjdhsuDKyxDm1BVj0TRKK17Qj6_QbZijL98VSgm1aqVWhfq8UDaGlCKM3S7iZOK-Y7R7zqcr-XQv-RT2bGHv0cH-_2C3uTpfNp4AMw-VwQ</recordid><startdate>202108</startdate><enddate>202108</enddate><creator>Park, Seung‐Hyun</creator><creator>Song, Young Woo</creator><creator>Cha, Jae‐Kook</creator><creator>Lee, Jung‐Seok</creator><creator>Kim, Young‐Taek</creator><creator>Shin, Hyun‐Seung</creator><creator>Lee, Dong‐Won</creator><creator>Lee, Jae Hyun</creator><creator>Kim, Chang‐Sung</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1410-9731</orcidid><orcidid>https://orcid.org/0000-0003-1852-7989</orcidid><orcidid>https://orcid.org/0000-0002-6906-7209</orcidid><orcidid>https://orcid.org/0000-0002-5132-5783</orcidid><orcidid>https://orcid.org/0000-0003-1835-5646</orcidid><orcidid>https://orcid.org/0000-0003-1276-5978</orcidid><orcidid>https://orcid.org/0000-0003-3902-1071</orcidid><orcidid>https://orcid.org/0000-0003-2739-281X</orcidid><orcidid>https://orcid.org/0000-0002-6207-8036</orcidid></search><sort><creationdate>202108</creationdate><title>Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial</title><author>Park, Seung‐Hyun ; Song, Young Woo ; Cha, Jae‐Kook ; Lee, Jung‐Seok ; Kim, Young‐Taek ; Shin, Hyun‐Seung ; Lee, Dong‐Won ; Lee, Jae Hyun ; Kim, Chang‐Sung</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3306-fc181f03254742654136ba2ec0b2640f5f6e9ee935b65db618358032258b764b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Antibiotics</topic><topic>Clinical trials</topic><topic>Debridement</topic><topic>Dentistry</topic><topic>Metronidazole</topic><topic>Minocycline</topic><topic>multicenter randomized controlled trial</topic><topic>nonsurgical therapy</topic><topic>Ointments</topic><topic>Patients</topic><topic>peri‐implantitis</topic><topic>Regression analysis</topic><topic>Success</topic><topic>Transplants & implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Park, Seung‐Hyun</creatorcontrib><creatorcontrib>Song, Young Woo</creatorcontrib><creatorcontrib>Cha, Jae‐Kook</creatorcontrib><creatorcontrib>Lee, Jung‐Seok</creatorcontrib><creatorcontrib>Kim, Young‐Taek</creatorcontrib><creatorcontrib>Shin, Hyun‐Seung</creatorcontrib><creatorcontrib>Lee, Dong‐Won</creatorcontrib><creatorcontrib>Lee, Jae Hyun</creatorcontrib><creatorcontrib>Kim, Chang‐Sung</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical implant dentistry and related research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Park, Seung‐Hyun</au><au>Song, Young Woo</au><au>Cha, Jae‐Kook</au><au>Lee, Jung‐Seok</au><au>Kim, Young‐Taek</au><au>Shin, Hyun‐Seung</au><au>Lee, Dong‐Won</au><au>Lee, Jae Hyun</au><au>Kim, Chang‐Sung</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial</atitle><jtitle>Clinical implant dentistry and related research</jtitle><date>2021-08</date><risdate>2021</risdate><volume>23</volume><issue>4</issue><spage>543</spage><epage>554</epage><pages>543-554</pages><issn>1523-0899</issn><eissn>1708-8208</eissn><abstract>Background
Clinical benefits of local antibiotics as an adjunct to nonsurgical treatment of peri‐implantitis have been widely reported, but most studies evaluated incipient peri‐implantitis lesions, and showed incomplete treatment success rates.
Purpose
To assess the clinical and microbiological outcomes of administering metronidazole in combination with minocycline as a local adjunct to the nonsurgical treatment of peri‐implantitis.
Materials and methods
One hundred and eighteen subjects with peri‐implantitis were recruited in a four‐center, three‐arm, and 12‐week randomized controlled trial. Subjects were randomly assigned to receive one of the following treatments: (a) MM—mechanical debridement + metronidazole‐minocycline ointment, (b) MC—mechanical debridement + minocycline ointment, (c) NST—mechanical debridement only.
Results
Except for four subjects who was excluded during the trial, a total of 114 patients with 114 implants (one implant per each patient) finally completed the trial and were included in the analyses. Multivariate logistic regression analysis revealed that the treatment success rates (absence of bleeding or suppuration on probing, and sites showing pocket probing depth [PPD] ≥5 mm) on at 12 weeks were higher in MM‐group patients (31.6%) and MC‐group patients (20.5%) compared to NST‐group patients (2.7%; p = 0.011 and 0.040, respectively). Subjects with deepest PPD ≥8 mm showed a significant difference in the PPD reduction between MM and MC groups at week 4 (p = 0.025) and week 12 (p = 0.047). Detection ratio of Tannerella forsythia was significantly lower for MM group than MC group (p = 0.038).
Conclusions
Additive use of either MM or MC results in significantly higher treatment success rates compared to sole mechanical debridement in nonsurgical treatment of peri‐implantitis. Moreover, MM contributes to a significantly greater reduction in the PPD compared to MC in deep pockets (cris.nih.go.kr KCT0004557).</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><doi>10.1111/cid.13006</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-1410-9731</orcidid><orcidid>https://orcid.org/0000-0003-1852-7989</orcidid><orcidid>https://orcid.org/0000-0002-6906-7209</orcidid><orcidid>https://orcid.org/0000-0002-5132-5783</orcidid><orcidid>https://orcid.org/0000-0003-1835-5646</orcidid><orcidid>https://orcid.org/0000-0003-1276-5978</orcidid><orcidid>https://orcid.org/0000-0003-3902-1071</orcidid><orcidid>https://orcid.org/0000-0003-2739-281X</orcidid><orcidid>https://orcid.org/0000-0002-6207-8036</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1523-0899 |
ispartof | Clinical implant dentistry and related research, 2021-08, Vol.23 (4), p.543-554 |
issn | 1523-0899 1708-8208 |
language | eng |
recordid | cdi_proquest_miscellaneous_2543446862 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | Antibiotics Clinical trials Debridement Dentistry Metronidazole Minocycline multicenter randomized controlled trial nonsurgical therapy Ointments Patients peri‐implantitis Regression analysis Success Transplants & implants |
title | Adjunctive use of metronidazole‐minocycline ointment in the nonsurgical treatment of peri‐implantitis: A multicenter randomized controlled trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T01%3A13%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adjunctive%20use%20of%20metronidazole%E2%80%90minocycline%20ointment%20in%20the%20nonsurgical%20treatment%20of%20peri%E2%80%90implantitis:%20A%20multicenter%20randomized%20controlled%20trial&rft.jtitle=Clinical%20implant%20dentistry%20and%20related%20research&rft.au=Park,%20Seung%E2%80%90Hyun&rft.date=2021-08&rft.volume=23&rft.issue=4&rft.spage=543&rft.epage=554&rft.pages=543-554&rft.issn=1523-0899&rft.eissn=1708-8208&rft_id=info:doi/10.1111/cid.13006&rft_dat=%3Cproquest_cross%3E2543446862%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2563679586&rft_id=info:pmid/&rfr_iscdi=true |